The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...
5h
Zacks Investment Research on MSNCVS Health (CVS) Rises Yet Lags Behind Market: Some Facts Worth KnowingThe most recent trading session ended with CVS Health (CVS) standing at $68.07, reflecting a +0.13% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a ...
SPX-USD lost over 4.5% in Q1 of 2025 due to economic uncertainty and trade war fears. Investor sentiment remains in Extreme ...
One pharmacy chain is offering vaccines to help combat measles following several confirmed cases in the state of Pennsylvania ...
The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...
A 10,856-square-foot building leased to CVS in Brandon has been sold. The property is at 715 W. Brandon Blvd., at the ...
Despite declining smoking rates, tobacco use remains a major public health concern. Dr. David Fairchild of CVS Health joins us to discuss the state of smoking in America, the challenges of quitting, ...
President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members ...
A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings. The former chair is not pleased.
CVS Health Corp. continues to fight a civil lawsuit that accuses the corporation and its retail pharmacists of wrongfully ...
In a motion to dismiss most claims, attorneys for the Woonsocket, R.I.-based company argue the DOJ failed to provide key ...
The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers. | The agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results